Medical and lifestyle interventions successfully lowered the risk of type 2 diabetes in women with a history of gestational diabetes.
Women with polycystic ovary syndrome (PCOS) are at increased risk for metabolic and heart diseases and nearly twice as likely to be hospitalized.
Watch for the onset of diabetes and other cardiovascular risk factors among gout patients, particularly women. A study using US insurance claims has validated UK data that showed the same gender difference.
A large population-based study, the first on the question to include women, stratifies an increased risk for type 2 diabetes among gout patients.
Contrave, a combination of naltrexone and buproprion, has been approved for long-term weight loss management in overweight and obese adults.
Black women born with low birth weight are at increased risk for the later development of type 2 diabetes mellitus, research shows.